Endovenous Versus Liposomal Iron in CKD

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT01864161

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01864161
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01864161. Randomized; no masking; primary purpose treatment. Start 2011-10 (registry gives no type); primary completion 2013-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Endovenous Versus Liposomal Iron in CKD
Condition
Iron Deficiency Anemia
Intervention (Drug)
gluconate iron
Intervention (Drug)
Liposomal iron
Lead sponsor
Federico II University (class: other)

Record details

Record id
cardio:ct-nct01864161
Content hash
e974d201ed67dce0b54b64a8a518480b1810374f5e1807f4512fb2a3ca71cc76